In collaboration with Cell & Gene Therapy Insights
The reliable supply of raw materials is critical for developing successful cell and gene therapies.
This webinar showcases how customization at the raw material level enables cell therapy manufacturers to be confident in the security of their supply, de-risk manufacturing processes, and improve their scalability.
In the first segment, Lindsey Clarke introduces the topic and Mitch Brabec discusses case studies that highlight the impact of customization on successful manufacturing processes. The second segment of the webinar is a panel discussion on how the right suppliers can fit products to manufacturers’ process to help expedite the path to commercialization.
Attendees will learn:
- How tailoring raw materials' specifications to fit the process can de-risk manufacturing processes and remove unnecessary manual steps
- Why early consideration of custom raw materials expedites development and commercialization
- Considerations for the selection of raw materials prior to clinical manufacturing
For more information on our Custom Services for Cell & Gene Therapy, visit us here
John Paul Tomtishen III
Director of Manufacturing, Technical Operations, Legend Biotech Co.
Lili Belcastro, PhD
Scientist, Biotherapeutics Material Sciences, Janssen Pharmaceutical R&D
Associate Director, Ms&T, Adaptimmune
Lindsey Clarke, PhD
Global Product Marketing & Commercial Strategy, Cell & Gene Therapy, Bio-Techne
Commercial Development Specialist, Bio-Techne